139 related articles for article (PubMed ID: 36284815)
1. Maintaining Myofibroblastic-Like Cancer-Associated Fibroblasts by Cancer Stemness Signal Transduction Feedback Loop.
Rogers MP; Kothari A; Read M; Kuo PC; Mi Z
Cureus; 2022 Sep; 14(9):e29354. PubMed ID: 36284815
[TBL] [Abstract][Full Text] [Related]
2. RNA Aptamer Targeting of Adam8 in Cancer Growth and Metastasis.
Mi Z; Kuo MC; Kuo PC
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370863
[TBL] [Abstract][Full Text] [Related]
3. Cancer stemness in bone marrow micrometastases of human breast cancer.
Kuo MC; Kothari AN; Kuo PC; Mi Z
Surgery; 2018 Feb; 163(2):330-335. PubMed ID: 28988933
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stem cell and epithelial hepatic carcinoma cell lines in admixture: concurrent stimulation of cancer-associated fibroblasts and epithelial-to-mesenchymal transition markers.
Bhattacharya SD; Mi Z; Talbot LJ; Guo H; Kuo PC
Surgery; 2012 Sep; 152(3):449-54. PubMed ID: 22938903
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.
Weber CE; Kothari AN; Wai PY; Li NY; Driver J; Zapf MA; Franzen CA; Gupta GN; Osipo C; Zlobin A; Syn WK; Zhang J; Kuo PC; Mi Z
Oncogene; 2015 Sep; 34(37):4821-33. PubMed ID: 25531323
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
8. RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.
Mi Z; Guo H; Russell MB; Liu Y; Sullenger BA; Kuo PC
Mol Ther; 2009 Jan; 17(1):153-61. PubMed ID: 18985031
[TBL] [Abstract][Full Text] [Related]
9. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
[TBL] [Abstract][Full Text] [Related]
11. Myeloid zinc finger-1 regulates expression of cancer-associated fibroblast and cancer stemness profiles in breast cancer.
Kuo MC; Kuo PC; Mi Z
Surgery; 2019 Oct; 166(4):515-523. PubMed ID: 31301870
[TBL] [Abstract][Full Text] [Related]
12. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway.
Zhang C; Ma K; Li WY
J Cancer; 2019; 10(26):6511-6525. PubMed ID: 31777581
[No Abstract] [Full Text] [Related]
13. CRISPR/Cas9 mediated knocking out of OPN gene enhances radiosensitivity in MDA-MB-231 breast cancer cell line.
Ghanbarnasab Behbahani R; Danyaei A; Teimoori A; Tahmasbi MJ; Neisi N
J Cancer Res Clin Oncol; 2023 Jul; 149(7):4117-4130. PubMed ID: 36042045
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells.
Talbot LJ; Mi Z; Bhattacharya SD; Kim V; Guo H; Kuo PC
Surgery; 2011 Aug; 150(2):224-30. PubMed ID: 21801960
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model.
Bhattacharya SD; Mi Z; Kim VM; Guo H; Talbot LJ; Kuo PC
Ann Surg; 2012 Feb; 255(2):319-25. PubMed ID: 22241292
[TBL] [Abstract][Full Text] [Related]
16. The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.
Hunter C; Bond J; Kuo PC; Selim MA; Levinson H
J Surg Res; 2012 Jul; 176(1):348-58. PubMed ID: 21962803
[TBL] [Abstract][Full Text] [Related]
17. Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells.
Hahnel A; Wichmann H; Kappler M; Kotzsch M; Vordermark D; Taubert H; Bache M
Radiat Oncol; 2010 Sep; 5():82. PubMed ID: 20849637
[TBL] [Abstract][Full Text] [Related]
18. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
Beausoleil MS; Schulze EB; Goodale D; Postenka CO; Allan AL
BMC Cancer; 2011 Jan; 11():25. PubMed ID: 21247495
[TBL] [Abstract][Full Text] [Related]
20. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
